
Package | Dosage | Price | Price per Dose | |
---|---|---|---|---|
Dosage: 135mg | ||||
240 pill | 135mg | NZD616.99 | NZD2.57 | |
120 pill | 135mg | NZD321.73 | NZD2.69 | |
90 pill | 135mg | NZD264.95 | NZD2.95 | |
60 pill | 135mg | NZD200.59 | NZD3.33 | |
30 pill | 135mg | NZD113.53 | NZD3.75 |

Colospa Description
Introduction to Colospa
Colospa, commonly known by its active ingredient mebeverine, is a medication frequently used in New Zealand to relieve symptoms associated with irritable bowel syndrome (IBS). Many individuals experience relief from abdominal pain and cramping after taking Colospa, making it a popular choice among those managing gastrointestinal discomfort. Its targeted action helps to relax the muscles in the intestines, easing spasm and improving overall digestive comfort.
How Does Colospa Work?
Colospa works by relaxing the smooth muscles of the gastrointestinal tract without affecting gut motility. This means it effectively reduces spasms and cramping without causing bowel sluggishness. Its mechanism helps to relieve common IBS symptoms such as abdominal pain, bloating, and irregular bowel movements. The medication is absorbed locally within the gut, which minimizes systemic side effects. In New Zealand, Colospa is available both by prescription and from certain pharmacies for over-the-counter use, depending on the specific formulation.
Usage and Dosage
Typically, Colospa is taken orally in the form of capsules. The usual dosage prescribed by healthcare providers in New Zealand involves taking one capsule three times daily before meals. It is important to follow the dosing instructions provided by your doctor or pharmacist. Consistency is key to managing symptoms effectively. Most users find that taking the medication as recommended helps to maintain relief from abdominal discomfort and improves quality of life.
Effectiveness and User Experiences
Many individuals in New Zealand report positive experiences with Colospa. They note that their IBS symptoms, especially pain and spasms, tend to decrease significantly after a few days of regular use. Some users appreciate that the medication is well-tolerated with minimal side effects. However, as with all medications, some might experience mild gastrointestinal disturbances such as nausea or occasional dizziness. It's always advisable to monitor how your body responds and consult a healthcare professional if symptoms persist or worsen.
Local Considerations in New Zealand
In New Zealand, the healthcare system supports the safe use of Colospa, often recommending it as part of a comprehensive approach to IBS management. Since dietary factors can influence symptoms, many users combine medication with dietary adjustments and stress reduction techniques. Pharmacists are well-informed and can provide guidance if you're considering starting Colospa, especially regarding potential interactions with other medications or underlying health conditions.
Conclusion
Overall, Colospa is regarded as an effective, well-tolerated option for managing IBS symptoms among many patients in New Zealand. Its targeted action on gut muscles helps to provide relief from persistent abdominal cramps and discomfort. As always, it is important to use this medication under medical supervision to ensure maximum benefit and safety. For those seeking a reliable treatment to improve daily comfort, Colospa remains a trusted choice within the local healthcare context.